Asghar Najjam 4
4 · Sorrento Therapeutics, Inc. · Filed Nov 13, 2020
Insider Transaction Report
Form 4
Asghar Najjam
Chief Financial Officer
Transactions
- Award
Stock Option
2020-11-12+120,000→ 120,000 totalExercise: $6.10Exp: 2030-11-12→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]1/4th of the original number of shares subject to the option shall vest on August 18, 2021, and 1/48th of the original number of shares subject to the option shall vest on a monthly basis thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.